DuPont said today that executive chairman Edward Breen would return to the CEO role as it removed CEO Mark Doyle and CFO Jeanmarie Desmond from their positions.
Lori Koch, vice president of investor relations and corporate financial planning and analysis has been named CFO. The changes are effective immediately.
“While we made some progress in 2019, we did not meet our own expectations and we now need to move aggressively to secure our foundation for growth,” said Breen. “We have solid businesses, but, as we discussed on our recent earnings call, we need to accelerate operational improvement and make sure we are taking appropriate action to deliver on our commitments for the year.”
DuPont said on its fourth-quarter earnings call that it would target $215 million of incremental savings from an ongoing restructuring program and was planning actions to deliver an additional $90 million of savings in 2020. The company said that Nick Fanandakis, former DuPont CFO, will serve as senior advisor to the CEO with a focus on driving the restructuring effort.
“After careful consideration, the board concluded now is the right time to make these leadership changes, including restoring Ed to the chief executive role to draw more directly on his substantial operating experience,” said Alexander Cutler, DuPont’s lead independent director. “The board is confident that together Ed and Lori will improve operational performance and ensure DuPont fully delivers on its significant potential for long-term value creation.”
Breen has served as executive chairman of DuPont since its separation from Corteva in June 2019 and previously served as CEO of DowDuPont since 2017. Breen said he “will be transitioning from the Corteva board to focus fully on our work at DuPont.” Prior to the merger of DuPont and Dow, Breen was Chairman and CEO of DuPont since 2015.
By Robert Westervelt
Source: Chemical Week
Lin will become the company’s Chief Transformation and Talent Officer. She will be responsible for Human Resources, Strategy and Business Consulting and drive the accelerated transformation of Bayer.
Johnson Matthey plc (JM; London) has confirmed that its battery cathode materials plant in Konin, Poland, will be powered solely by electricity from renewable sources from day one of production.
Britain’s Oxford University has received a donation of £100 million (112 million euros, $136 million) to research growing resistance to antibiotics, the university announced on Tuesday. The sum, from British chemicals multinational Ineos, is one of the largest donations given to Oxford University in its long history.